Millennium Management’s Clementia Pharmaceuticals CMTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-273,286
Closed -$7.13M – 4763
2019
Q1
$7.13M Buy
273,286
+248,426
+999% +$4.64M 0.01% 1516
2018
Q4
$292K Buy
+24,860
New +$309K ﹤0.01% 3228
2018
Q1
– Sell
-10,319
Closed -$196K – 4304
2017
Q4
$196K Sell
10,319
-181,655
-95% -$3.04M ﹤0.01% 3539
2017
Q3
$3.24M Buy
+191,974
New +$3.14M ﹤0.01% 1905

Millennium Management's CMTA Position: Q2 2019 in Review

Millennium Management sold out of Clementia Pharmaceuticals (CMTA) in Q2 2019, closing a stake of 273,286 shares — an estimated $7.13M sold.

Millennium Management first reported a position in CMTA in Q3 2017 and held it in 4 quarters. The position peaked at $7.13M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Millennium Management reported no remaining Clementia Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Millennium Management sold 273,286 Clementia Pharmaceuticals shares in Q2 2019, an estimated $7.13M.
  • Millennium Management first reported a position in Clementia Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • Millennium Management's Clementia Pharmaceuticals position peaked at $7.13M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals as of Q2 2019.

Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.